BLOCK 1. Immunology and Principles of Vaccination

Similar documents
In ensuring the safety of veterinary vaccines demonstration of freedom from EA is one of high importance.

Issue 3: Policy Considerations for Different Product Types. Mark Zylstra April 22, 2015

Reduction, Refinement and Replacement of Animals in Biological Testing. Animal Health Firm s Perspective VBS Public Meeting April 6, 2004

Synopsis of Issues Concerning 9 CFR and VSM

Alternatives to In-Vivo Testing for Animal Biologics: North American Regulatory Perspective

CVB Budget Comparison

Elimination of target safety testing and the development of In-vitro assays for testing of livestock vaccines. by Dr G McKay and Dr R P Dempster

Potency Specifications for Serial Release and Throughout Dating

JGK TRAINING PROGRAMME MODULE 2: METHOD VALIDATION AND UNCERTAINTY OF MEASUREMENT FOR VETERINARY LABORATORIES SAVC REF. ACCREDITATION NO.

Historical Perspective on Regulation of Potency of USDA Regulated Vaccines

Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE

Regulatory Status of Veterinary Medicinal Products (VMPs)- An Indian Perspective. S.N.Singh

Science & Technology Directorate

TRAINING COURSE ON. September 18-22, 2006

HIGH SCHOOL STUDENT SCIENCE WEEK. St. Paul s Hospital Vancouver, BC

Risk Assessments for Host Cell Protein Control Strategies: CDER Experiences

Flow Cytometry 2013 July 22-26

GMP, GLP OR ISO 17025: HOW DO THESE APPLY TO OUTSOURCED ANALYTICAL TESTING?

London, 11 October 2006 Doc. Ref. EMEA/CHMP/BWP/271475/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Requirements for Vaccines in Other Regions of the World

PRAXIS. A publication by Bioengineering AG

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products

Critical Steps for Approval of Adjuvanted Pandemic Vaccines

Advanced Certificate in Biopharmaceutical Manufacturing

National Veterinary Institute (NVI)

Advanced Certificate in Biopharmaceutical Manufacturing

Regulatory aspects of veterinary vaccine development. A. R. Peters University of Edinburgh And Arpexas (Scotland) Ltd.

Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services

Considerations in Product Development with Advanced Therapies and Cancer Vaccines

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

Guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines

OIE Reference Laboratory Reports Activities

BSA FRACTION V BOVINE SERUM ALBUMIN

Comparative Study of Regulatory Requirements for Biologics Filing in United States and European Union

Explanatory note on general fees payable to the European Medicines Agency

PRINCIPLES OF VETERINARY VACCINE PRODUCTION

EUROPEAN COMMISSION HEALTH & FOOD SAFETY. Directorate G Veterinary and International affairs. Unit G2- Animal health

Critical Quality Attributes for Live Viral Vaccines. Mark S. Galinski Vaccine Analytical Sciences, MedImmune, Mountain View, CA USA

The Road to Licensure of a DNA Vaccine for Atlantic Salmon

TRAINING COURSE ON MOLECULAR MARKER TECHNIQUES AND FINGERPRINTING AGRICULTURAL GENETIC ENGINEERING RESEARCH INSTITUTE (AGERI)

CMC Strategy Forum Japan November Piyanan Boonprasirt Bureau of Drug Control Thailand Food and Drug Administration

NIAID Resources to Facilitate Medical Countermeasure Development

2012 Stakeholder Workshop. Research Surveillance Outreach/education

International. Recruiting Briefing

Course Agenda. Day One

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

Explanatory note on general fees payable to the European Medicines Agency

Process Validation for FDA Regulated Industries

Beth Hutchins, PhD PhRMA ICH Gene Therapy Discussion Group

Guidance for Industry

Immunofluorescence Assays for Autoimmune and Infectious Disease

Explanatory note on fees payable to the European Medicines Agency

OIE Reference Laboratory Reports Activities

Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm Rockville, MD 20852

Regulatory Challenges for the Licensure of Future Vaccines

Protecting American Agriculture

Organization Audit An excellent start to create a more profitable business. March 2016

Time Efficiencies to Be Gained from Platform Approaches to Drug Development

GUIDELINES FOR REGISTRATION OF VETERINARY BIOLOGICALS

OUR MISSION OUR EXPERTISE OUR SERVICES

Explanatory note on fees payable to the European Medicines Agency

2019 Sponsorship Information

New proposal from the EC:

International Supply Chain: How are we handling globalisation? GCP oversight

"From Bedside to Bench and Back: regulatory requirements for collaborations between pharma industry and academia

Synthetic vaccine research and development. Comprehensive and innovative synthetic biology solutions and technologies

A Life Cycle Approach to Raw Material Qualification for Cell and Gene Therapy Products

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

The Biotechnology Industry in Taiwan

Immunogenicity: Impact on the Design of Clinical Trials for Biosimilars

Training course on. The Analysis of Food and Feed Samples for the Presence of Genetically Modified Organisms

Sponsorship Opportunities Spring Meeting. May 7 9 Hyatt Regency Baltimore Inner Harbor Baltimore, Maryland

WHO PQ dossier Module I. DCVMN Common Technical Document (CTD) Workshop Brazil, 18 to 20 June 2018 Dr. Nora Dellepiane

VACCINES CONSISTENCY APPROACH PROJECT

Guidance for Industry

FDA/JIFSAN Train-the-Trainers Good Aquaculture Practices Program Sample Training Course Agenda

Guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines. Proposed guidelines

Sponsorship Opportunities

Pre- ICDRA Exhibition Guide

Guide to Fees for Veterinary Products

Laboratory Perspective: The challenge of standardisation in the face of the revolution in biotechnology and data processing

Regulatory Approval of Modern Gene-Based Cancer Immunotherapies CAR T Cells A product perspective

ACVM REGISTRATION STANDARD AND GUIDELINE FOR EFFICACY OF VACCINES

Development and Evaluation of an Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Bovine Tuberculosis

Vaccine Congress 2017

The Regulatory Environment for Therapeutic Vaccines. Thomas Hinz Head, Section Therapeutic Vaccines Paul Ehrlich Institute, Germany

CONTRACTORS ASSOCIATION OF WEST VIRGINIA PRESENTS THE SECOND ADDITION OF THE 2019 TECHNICIAN & INSPECTOR CERTIFICATION TRAINING COURSES

USP Standards for Ancillary Materials

The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual.

2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast

This package contains: Program Overview Summary of Events Criteria Workshop Descriptions Career options Application form

Roche to present new data at AAN reinforcing efficacy and safety of newly FDAapproved OCREVUS (ocrelizumab) in two types of multiple sclerosis

Risk Based Incoming Quality Assurance (IQA)

REGULATION OF BIOLOGICAL PRODUCTS IN PERU. Vicky Roxana Flores Valenzuela General Directorate of Medicines, Supplies and Drugs (DIGEMID)

3Rs in Quality control of vaccines for human use: opportunities and barriers

Product Testing & Release. PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 4 th /5 th, 2006

Filling and Packaging Validation for FDA Regulated Industries

MODULE 3 Preclinical safety May 2016 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES

Transcription:

The Institute for International Cooperation in Animal Biologics (IICAB) is offering a twelve-day Veterinary Biologics Training Program beginning May 10, 2011 in Ames, Iowa. The course is sponsored by the USDA Animal and Plant Health Inspection Service s (APHIS) Center for Veterinary Biologics (CVB). The USDA sponsors have concentrated their veterinary biologics training into one consolidated course per year. Individuals interested in obtaining veterinary biologics training at USDA facilities in Ames are strongly encouraged to obtain that training through this course. Course Objective: This course will give participants an overview of the scientific principles of vaccines and vaccination and of the USDA regulatory process for assuring the purity, safety, potency, and efficacy of veterinary biologics. Intended Participants: The intended participants are regulatory officials from countries throughout the world and biologics company employees. More than 1130 industry representatives and 498 international representatives from 82 countries have attended portions of the Program in the past fifteen years. The number of participants is limited for some sections of the course and government regulatory officials receive priority acceptance into the Program. BLOCK 1 Immunology and Principles of Vaccination Block 1 is intended for individuals who have not recently studied immunology who want an overview and update of immunology as it applies to resistance to infectious diseases. Presented by James A. Roth, IICAB, Iowa State University Tuesday, May 10 1:00 p Welcome and Introduction of the Course and Participants 1:30 p Basic Immunology Introduction, Phagocytosis, Complement system WELCOME RECEPTION Wednesday, May 11 8:30-11:50 a Basic Immunology Interferons, Lymphocytes, Antibodies and antigens, Cell-mediated immunity 11:50 a LUNCH 1:00-5:00 p Basic Immunology Antigen processing and presentation, Lymphocyte antigen recognition, activation and effector mechanisms, Lymphocyte circulation, Mucosal immunity Thursday, May 12 8:30-11:50 a Basic Immunology Fetal and neonatal immunity, Mechanisms of hypersensitivity, Evaluation of cell-mediated immunity 11:50 a LUNCH Certificate Presentations

BLOCK 1 1:00-5:00 p Comparative immunology Principles of vaccination Vaccine safety and efficacy Friday, May 13 8:30 a-11:50 a Vaccine safety and efficacy (cont), Overview of biotechnology derived biologics, Adjuvants NO LUNCH PROVIDED BLOCK 2 Procedures for Ensuring Vaccine Safety and Efficacy Block 2 will review the requirements and processes for licensing/registration and testing of veterinary biological products and will review the inspection and compliance process. Presented by USDA CVB Staff. Monday, May 16 8:30 a Welcome and Introduction of Participants 9:30 a Instructions to Participants 9:40 a BREAK 9:50 a Introduction to the Center for Veterinary Biologics 10:20 a Quality Manufacturing Standards for Veterinary Biologics Parallels: 9CFR and GMP and Harmonization 11:10 a Introduction to Policy, Evaluation and Licensing (PEL) Optional Presentation: Brucellosis 1:00 p General Licensing Requirements in the US 145 p BREAK 1:55 p Outline of Production 2:55 p BREAK 3:05 p Efficacy Requirements 3:55-4:15 p Interference Studies EVENING WELCOME RECEPTION AT REIMAN GARDENS FOR ALL ATTENDEES Tuesday, May 17 8:30 a Statistical Considerations for Vaccine Trials 9:40 a Licensing of Veterinary Diagnostic Test Kits 10:30 a Importation of Biological Products for Distribution and Sale 11:10 a Regulating Products of Biotech Origin

BLOCK 2 Optional Presentation: Aquaculture Biologics Optional Presentation: Statistical Considerations of Vaccine Trials: Examples 1:00 p Summary Information Format and Risk Analysis 1:50 p Regulatory Considerations for Nucleic Acid-Mediated Veterinary Vaccines 2:20 p BREAK 2:30 p Autogenous Biologics 3:10-3:40 p Poultry Specific Licensing Issues Wednesday, May 18 8:30 a Review of New Products 9:15 a Safety Requirements 9:50 a BREAK 10:00 a Master Seed Testing 10:40 a In vitro Potency Testing of Live and Inactivated Vaccines 11:30 a National Veterinary Stockpile/Avian Influenza Biologics 12:10 p LUNCH 1:10 p FDA-EREA Regulations and CVB 1:35 p US Vaccine Label Regulations 2:15 p BREAK 2:25 p Agent Biosecurity and Reference Management 2:45-3:20 p Regulatory Considerations for Transgenic Plant-Derived Veterinary Biologics 3:30 p USDA NCAH Tour Thursday, May 19 8:30 a Introduction to Center for Veterinary Biologics, Inspection and Compliance (IC) 9:00 a CVB Inspection Program 9:40 a Inspection Categories 10:50 a BREAK 11:00 a Record Keeping and Documentation 11:50 a LUNCH Certificate Presentations 1:00 p Compliance Activities 1:40 p BREAK

BLOCK 2 1:50 p Inspection Workshop 3:20 p BREAK 3:30 p Pharmacovigilance 4:05-5:00 p Export Products from the US EVENING BARBECUE for all attendees at Dr. Roth s home Friday, May 20 8:30 a Panel Discussion CVB Management 9:40 a Product Inspection and Release 10:25 a Common Errors & Other Form 2008 Uses 11:10 a Quality Assurance and Quality Management 11:55 p LUNCH Optional Presentation: Overview of the CVB Website 1:00 p APHIS Form 2008 Workshop 1:50 p BREAK 2:00 p APHIS Form 2008 Workshop (cont) 2:40 p BREAK 3:00-4:30 p Sample Evaluation Workshop BLOCK 3 (International Government Participants Only) Laboratory Testing Related to Biologics Evaluation Block 3 will review the principles and procedures for the laboratory testing of biologics and diagnostic test kits. Presented by USDA CVB Staff. Monday, May 23 Virology Laboratory 8:30 a Overview of Testing at the Virology Laboratory 9:00 a Real Time RT-PCR 1:00-1:45 p Egg Inoculation, Primary CEF s, and Hemadsorption Tuesday, May 24 Bacteriology Laboratory 8:30 a Overview of Testing at the Bacteriology Laboratory 9:00 a Potency ELISA

BLOCK 3 1:00-3:00 p Potency ELISA (cont d) and Mycoplasma Testing BID Laboratory 3:00 p Overview of MS Testing at the BID Laboratory 3:30-5:00 p DNA Isolation and/or E-gels and Analysis Wednesday, May 25 BID Laboratory (cont d) 8:30 a Overview of Diagnostic Test Kit Testing 9:00 a Test Kits and SDS-PAGE/Western Blot and Analysis 1:00-5:00 p Test Kits and SDS-PAGE/Western Blot and Analysis (cont d) For more information please contact the IICAB Office: Institute for International Cooperation in Animal Biologics, 2160 College of Vet Med, Iowa State Univ, Ames, IA 50011 Phone: 515.294.7632 Fax: 515.294.8259 Email: iicab@iastate.edu http://www.cfsph.iastate.edu/iicab/